SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899866-21-000073
Filing Date
2021-07-23
Accepted
2021-07-23 16:48:29
Documents
1
Period of Report
2021-07-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162707329280008.html 4  
1 FORM 4 wf-form4_162707329280008.xml 4 3959
  Complete submission text file 0000899866-21-000073.txt   5421
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Issuer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Dunsire Deborah (Reporting) CIK: 0001332764 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27756 | Film No.: 211111428